Labiana Pharmaceuticals launches PRECYST, the new nutritional supplement to improve the health of urinary system in women

Home / News / Labiana Pharmaceuticals launches PRECYST, the new nutritional supplement to improve the health of urinary system in women

An average of 30% of women who suffer from cystitis get an infection more than twice a year. Acute cystitis is the most common amongst the urinary tract infections in women with an average of 50%-60%. To cover these needs, Labiana Pharmaceuticals launches a new nutritional supplement, PRECYST.

Thanks to the experience of more than 60 years in the pharmaceutical industry, Labiana certifies the highest quality and effectiveness of all its products. Like in other areas (scientific, medical, development, commercial etc.), Labiana team used its broad knowledge to develop PRECYST.

PRECYST, together with our product fosfomycin trometamol, allows us to expand the range of products for women’s health. Its composition is based on two natural ingredients that have synergistic effects, D-Mannose and cranberry extract. Their association is effective and clinically proven by many studies for preventing recurrent urinary tract infections in women, mainly caused by the bacterium Escherichia Coli. PRECYST is complementary to antibiotic treatments. PRECYST presentation, with boxes of 14 sticks, is designed to facilitate regular intake. It is manufactured according to our specifications and high-quality standards in laboratories specialized in food supplements.

Labiana has a great knowledge of women health treatments as it owns and manufactures fosfomycin trometamol for treating acute uncomplicated cystitis.

Labiana aims to find the right customers to offer the use of the brand PRECYST, adding the possibility of adapting the packaging design to the specific needs of each market. Moreover, PRECYST has been notified in European Union countries and can be approved in other countries based on specific regulations related to food supplements.

At Labiana Pharmaceuticals we are confident with the launch of PRECYST and in the coming years we will increase our efforts to expand our product portfolio for human and women’s health.

Utilizamos cookies propias y de terceros para mejorar nuestros servicios y mostrarle información relacionada con sus preferencias, mediante el análisis de sus hábitos de navegación. Si continúa navegando, consideramos que acepta su uso. Puede cambiar la configuración u obtener más información visitando nuestra Política de Cookies

We use own and third-party cookies to improve our services and show information related to your preferences by analyzing your browsing habits. If you continue browsing, we will consider that you allow us to use them. You can change the settings or get more information on our Cookies policy

Nous utilisons nos propres cookies et celles de tiers pour améliorer nos services et vous proposer des informations relatives à vos préférences, en analysant vos habitudes de navigation. Si vous poursuivez la navigation, nous estimons que vous acceptez l’utilisation des cookies. Vous pouvez modifier les paramètres ou obtenir plus d'informations en nous rendant visite sur notre politique relative aux cookies

Aviso de cookies